SARS-CoV-2 Variant B.1.351 (lsolate:South_Africa/KRISP-K005325/2020) Culture Fluid (UV Inactivated)

SARS-Related Coronavirus 2 Lineage B.1.351; Beta Variant (Isolate: South_Africa/KRISP-K005325/2020) is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus. Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate hCoV-19/South Africa/KRISPK005325/2020 (also referred to as 501Y.V2.HV and 501Y.V2.HV001) was isolated from an oropharyngeal swab from a 40-year-old human male in Ugu district, KwaZulu-Natal, South Africa on November 16, 2020. Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARSCoV-2, isolate hCoV-19/South Africa/KRISPK005325/2020 is assigned lineage B.1.351 and GISAID clade GH using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool. The complete genome of the clinical isolate of SARS-CoV-2, hCoV-19/South Africa/KRISP-K005325/2020 has been sequenced (GISAID: EPI_ISL_678615). Each frozen aliquot contains 1 mL of UV inactivated, clarified viral culture fluid. The pre-inactivation titer was determined from an infectious aliquot. Viral inactivation is verified after UV inactivation by the absence of viral growth in tissue culture-based infectivity assays.

For BSL-2 or BSL-3 compliant labs only. CCL required / -20° C.
Product Insert.pdf

Material Safety Data Sheet.pdf